Development and Multicentric Validation of a Lateral Flow Immunoassay for Rapid Detection of MCR-1-Producing


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
05 2019
Historique:
received: 07 09 2018
accepted: 15 02 2019
pubmed: 8 3 2019
medline: 16 7 2020
entrez: 8 3 2019
Statut: epublish

Résumé

Colistin has become a last-resort antibiotic for the treatment of infections caused by highly drug-resistant Gram-negative bacteria. Moreover, it has been widely used in the livestock sector. As a consequence, colistin resistance is emerging worldwide. Among the colistin resistance mechanisms, the spread of the plasmid-encoded colistin resistance gene

Identifiants

pubmed: 30842227
pii: JCM.01454-18
doi: 10.1128/JCM.01454-18
pmc: PMC6498016
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Escherichia coli Proteins 0
MCR-1 protein, E coli 0
Colistin Z67X93HJG1

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 Volland et al.

Références

Clin Infect Dis. 2005 May 1;40(9):1333-41
pubmed: 15825037
Chemotherapy. 2010;56(6):448-52
pubmed: 21088396
Clin Microbiol Infect. 2011 Nov;17(11):E9-E11
pubmed: 21939468
Clin Microbiol Infect. 2014 Feb;20(2):O117-23
pubmed: 23992130
Front Microbiol. 2014 Nov 26;5:643
pubmed: 25505462
Lancet Infect Dis. 2016 Feb;16(2):161-8
pubmed: 26603172
J Antimicrob Chemother. 2016 Jul;71(7):1834-40
pubmed: 26968882
J Antimicrob Chemother. 2016 Aug;71(8):2318-20
pubmed: 27121402
Euro Surveill. 2016 Jul 7;21(27):
pubmed: 27416987
New Microbes New Infect. 2016 Jul 05;13:71-4
pubmed: 27489722
BMC Biol. 2016 Sep 21;14(1):81
pubmed: 27655155
J Microbiol Methods. 2017 Jan;132:125-127
pubmed: 27894831
Clin Infect Dis. 2017 Mar 15;64(6):711-718
pubmed: 27940944
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 27993847
Sci Rep. 2016 Dec 21;6:39540
pubmed: 28000749
Antimicrob Agents Chemother. 2017 Mar 24;61(4):
pubmed: 28137796
Int J Antimicrob Agents. 2017 May;49(5):526-535
pubmed: 28163137
Clin Microbiol Rev. 2017 Apr;30(2):557-596
pubmed: 28275006
J Glob Antimicrob Resist. 2017 Jun;9:57-60
pubmed: 28400211
MBio. 2017 Jun 27;8(3):
pubmed: 28655818
J Clin Microbiol. 2017 Oct;55(10):3138-3141
pubmed: 28768732
Euro Surveill. 2017 Aug 3;22(31):null
pubmed: 28797329
Clin Microbiol Infect. 2018 Feb;24(2):201.e1-201.e3
pubmed: 28827120
Euro Surveill. 2017 Aug 31;22(35):
pubmed: 28877845
J Antimicrob Chemother. 2017 Dec 1;72(12):3317-3324
pubmed: 28962028
Int J Antimicrob Agents. 2018 Jan;51(1):163-164
pubmed: 29180277
J Antimicrob Chemother. 2018 Feb 1;73(2):533-536
pubmed: 29182716
Antimicrob Agents Chemother. 2018 Jan 25;62(2):
pubmed: 29203482
Nat Commun. 2017 Dec 12;8(1):2054
pubmed: 29233990
J Clin Microbiol. 2018 Feb 22;56(3):
pubmed: 29237785
J Antimicrob Chemother. 2018 Apr 1;73(4):909-915
pubmed: 29365094
Euro Surveill. 2018 Feb;23(6):
pubmed: 29439754
J Antimicrob Chemother. 2018 Jun 1;73(6):1721-1723
pubmed: 29462314
Trends Microbiol. 2018 Sep;26(9):794-808
pubmed: 29525421
J Antimicrob Chemother. 2018 Jul 1;73(7):1791-1795
pubmed: 29912417
Emerg Microbes Infect. 2018 Jul 4;7(1):122
pubmed: 29970891
Diagn Microbiol Infect Dis. 2018 Dec;92(4):267-269
pubmed: 30220493
Int J Antimicrob Agents. 2019 Mar;53(3):302-309
pubmed: 30395987

Auteurs

Hervé Volland (H)

Service de Pharmacologie et Immuno-analyse (SPI), JOLIOT, CEA, INRA, Université Paris-Saclay, Gif sur Yvette, France herve.volland@cea.fr.

Laurent Dortet (L)

EA7361, UPSUD, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Hôpital de Bicêtre, APHP, Le Kremlin Bicêtre, France.

Sandrine Bernabeu (S)

EA7361, UPSUD, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Hôpital de Bicêtre, APHP, Le Kremlin Bicêtre, France.

Hervé Boutal (H)

Service de Pharmacologie et Immuno-analyse (SPI), JOLIOT, CEA, INRA, Université Paris-Saclay, Gif sur Yvette, France.

Marisa Haenni (M)

Unité Antibiorésistance et Virulence Bactériennes (AVB), Université de Lyon-Anses, Lyon, France.

Jean-Yves Madec (JY)

Unité Antibiorésistance et Virulence Bactériennes (AVB), Université de Lyon-Anses, Lyon, France.

Frédéric Robin (F)

CHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France.

Racha Beyrouthy (R)

CHU Clermont-Ferrand, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France.

Thierry Naas (T)

EA7361, UPSUD, Laboratoire de Bactériologie & CNR de la Résistance aux Antibiotiques, Hôpital de Bicêtre, APHP, Le Kremlin Bicêtre, France.

Stéphanie Simon (S)

Service de Pharmacologie et Immuno-analyse (SPI), JOLIOT, CEA, INRA, Université Paris-Saclay, Gif sur Yvette, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH